US Patent Issued to ALIAD BIOPHARMA on April 21 for "Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,358, issued on April 21, was assigned to ALIAD BIOPHARMA (Yongin-si, South Korea).

"Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient" was invented by Yunhee Kim (Seoul, South Korea), Hyockman Kwon (Seoul, South Korea) and Young Taek Han (Cheonan-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel compound that inhibits the mTOR signaling pathway, a method for preparing same, and a pharmaceutical composition comprising same as an active ingredient. The compound of the present invention was found to inhibit m...